Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	35,596	55,558	36,109	28,508	59,346	-
Market Cap Growth	-39.10%	53.86%	26.67%	-51.96%	-	-
Enterprise Value	25,673	48,535	30,432	20,657	47,493	-
PS Ratio	44.42	45.32	47.92	36.68	284.42	-
PB Ratio	1.85	2.58	4.61	3.01	5.33	-
P/TBV Ratio	3.45	4.85	5.70	3.02	5.35	-
EV/Sales Ratio	34.20	39.59	40.38	26.58	227.62	-
Debt / Equity Ratio	0.08	0.11	0.11	0.11	0.00	0.05
Asset Turnover	0.04	0.06	0.07	0.06	0.02	0.02
Quick Ratio	4.39	3.43	4.24	5.51	11.27	11.36
Current Ratio	4.60	3.81	4.70	5.68	11.46	11.54
Return on Equity (ROE)	-91.06%	-61.90%	-69.12%	-46.56%	-47.51%	-54.57%
Return on Assets (ROA)	-42.04%	-28.48%	-32.29%	-23.42%	-25.14%	-26.44%
Return on Capital Employed (ROCE)	-57.50%	-38.00%	-62.50%	-40.90%	-32.40%	-30.70%
Earnings Yield	-36.87%	-17.39%	-15.36%	-16.39%	-6.44%	-
FCF Yield	-23.07%	-13.98%	-14.03%	-8.25%	-6.85%	-
Buyback Yield / Dilution	-63.30%	-31.92%	-18.41%	-40.04%	-475.48%	-0.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.